A Phase I/II Trial of Hydroxychloroquine in Conjunction With Radiation Therapy and Concurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hydroxychloroquine; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2019 Biomarkers information updated
- 01 May 2012 Planned End Date changed from 1 Jun 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.
- 27 Jun 2011 Planned end date changed from 1 Jun 2009 to 1 Jun 2012 as reported by ClinicalTrials.gov.